More than 20,000 US federal workers sign up for buyout offer
(Reuters) – Over 20,000 U.S. federal employees, roughly 1% of the government workforce, have signed up for an offer to quit their jobs, a source
Palantir shares jump on upbeat revenue outlook as businesses adopt AI
(Reuters) – Palantir shares rallied over 18% in premarket trading after it forecast upbeat annual revenue fueled by strong demand for its software and data
PayPal’s profit push slows unbranded business growth, shares drop 10%
By Manya Saini (Reuters) -PayPal’s shares fell nearly 10% on Tuesday, after the digital payments giant’s unbranded card processing business saw a sharp slowdown in
Merck stops Gardasil shipments to China, hitting 2025 outlook; shares tumble
By Michael Erman and Mariam Sunny (Reuters) -Merck said on Tuesday it would not ship its HPV vaccine Gardasil in China until at least the
Tesla loses market share in Sweden, Norway as Musk looms large
OSLO (Reuters) – Tesla lost market share in Sweden and Norway in January, car registration data showed on Monday as the U.S. electric vehicle maker
DeepSeek gives Europe’s tech firms a chance to catch up in global AI race
By Supantha Mukherjee GOTHENBURG (Reuters) – Hemanth Mandapati, boss of German startup Novo AI, was an early adopter of DeepSeek chatbots when he switched to
Analysis-Trump plans to invoke obscure 18th century wartime law in bid for mass deportations
By Ted Hesson and Kristina Cooke WASHINGTON – President Donald Trump is set to test the limits of his immigration crackdown by invoking a wartime
US metal buyers likely to turn to Mideast, Chile as tariffs bite
By Melanie Burton MELBOURNE (Reuters) -U.S. companies will look to the Middle East and India for more aluminium and to Chile and Peru for copper
US Senate panel to vote on RFK Jr.’s health secretary nomination
(Reuters) – A U.S. Senate committee will vote Tuesday on whether to advance President Donald Trump’s nomination of Robert F. Kennedy Jr. to lead the
Pfizer resolves conservative challenge to diversity fellowship program
By Nate Raymond (Reuters) – Pfizer has resolved a lawsuit by a conservative group that alleged that a fellowship program that the drugmaker established to